Profile for Singapore Patent: 170772
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Singapore Patent: 170772
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
⤷ Sign Up | Feb 23, 2029 | Novartis | TASIGNA | nilotinib hydrochloride |
⤷ Sign Up | Jan 18, 2027 | Novartis | TASIGNA | nilotinib hydrochloride |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |